This two-day course will provide a multidisciplinary review of nonmelanoma skin cancer (NMSC) and malignant melanoma (MM) with respect to current standards of practice and advances in treatment. The first day will review advances in melanoma treatment and the second day will review treatment of NMSC such as Merkel cell carcinoma, and high risk basal cell (BCC) or squamous cell carcinoma (SCC).
Register Today!3rd Annual Mayo Clinic Cutaneous Oncology Symposium
